These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3882257)

  • 1. Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.
    Bosanquet AG
    Cancer Chemother Pharmacol; 1985; 14(2):83-95. PubMed ID: 3882257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography.
    Bosanquet AG; McLoughlin SB
    Invest New Drugs; 1985; 3(1):43-50. PubMed ID: 3838738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of melphalan solutions during preparation and storage.
    Bosanquet AG
    J Pharm Sci; 1985 Mar; 74(3):348-51. PubMed ID: 4009450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid bioassay to determine stabilities of anticancer agents under conditions of the clonogenic assay.
    Hildebrand-Zanki SU; Kern DH
    In Vitro Cell Dev Biol; 1986 May; 22(5):247-52. PubMed ID: 3710996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorambucil: stability of solutions during preparation and storage.
    Bosanquet AG; Clarke HE
    Cancer Chemother Pharmacol; 1986; 18(2):176-9. PubMed ID: 3791562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of alkylating activity and mutagenicity in bacteria of cytostatic drugs.
    Hemminki K; Kallama S; Falck K
    Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):421-8. PubMed ID: 6659971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro.
    Jähde E; Glüsenkamp KH; Klünder I; Hülser DF; Tietze LF; Rajewsky MF
    Cancer Res; 1989 Jun; 49(11):2965-72. PubMed ID: 2720657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
    Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
    Oguro M; Yanagawa T; Takenaga K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of alkylating agents.
    Lind MJ; Ardiet C
    Cancer Surv; 1993; 17():157-88. PubMed ID: 8137340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced nitrosourea cytotoxicity in cell culture by sodium butyrate.
    Vu VT; Moy BC; Schein PS; Tew KD
    Oncology; 1985; 42(5):317-21. PubMed ID: 3162128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
    Aida T; Bodell WJ
    No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
    Goldenberg GJ
    Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of computerized morphonuclear and multivariate analyses to characterize in vitro the antineoplastic effect of alkylating agents.
    Pauwels O; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 1995 Feb; 33(1):35-45. PubMed ID: 7727807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of labeled molecules in the pharmacokinetic study of alkylating agents (chlorambucil, melphalan, mitoclomine) and glycosyl nitrosoureas (RFCNU and RPCNU)].
    Meyniel G; Godenech D
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XXXIII-XXXV. PubMed ID: 545309
    [No Abstract]   [Full Text] [Related]  

  • 20. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
    Kaiser J; Thiesen J; Krämer I
    J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.